KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
-3.86%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$311M
AUM Growth
+$311M
Cap. Flow
+$31.8M
Cap. Flow %
10.22%
Top 10 Hldgs %
95.85%
Holding
13
New
1
Increased
9
Reduced
3
Closed
–

Top Buys

1
ALXN
Alexion Pharmaceuticals Inc
ALXN
$13.3M
2
ENTA icon
Enanta Pharmaceuticals
ENTA
$10.8M
3
TARO
Taro Pharmaceutical Industries Ltd.
TARO
$9.02M
4
UTHR icon
United Therapeutics
UTHR
$7.46M
5
ALKS icon
Alkermes
ALKS
$3.79M

Top Sells

1
REGN icon
Regeneron Pharmaceuticals
REGN
$8.6M
2
MCK icon
McKesson
MCK
$4.87M
3
GILD icon
Gilead Sciences
GILD
$307K

Sector Composition

1 Healthcare 97.87%
2 Technology 0.01%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$13.8B
$51.2M 16.46% 539,646 +78,702 +17% +$7.46M
REGN icon
2
Regeneron Pharmaceuticals
REGN
$61.5B
$42.4M 13.64% 86,817 -17,603 -17% -$8.6M
ALXN
3
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$41.5M 13.35% 462,138 +148,582 +47% +$13.3M
ENTA icon
4
Enanta Pharmaceuticals
ENTA
$180M
$36M 11.58% 700,318 +210,933 +43% +$10.8M
BIIB icon
5
Biogen
BIIB
$19.4B
$35M 11.27% 110,771 +867 +0.8% +$274K
TARO
6
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$29.8M 9.59% 487,275 +147,456 +43% +$9.02M
MCK icon
7
McKesson
MCK
$85.4B
$29.5M 9.5% 218,306 -36,024 -14% -$4.87M
ALKS icon
8
Alkermes
ALKS
$4.78B
$16.8M 5.42% 1,167,631 +262,553 +29% +$3.79M
GILD icon
9
Gilead Sciences
GILD
$140B
$8.8M 2.83% 117,755 -4,106 -3% -$307K
SRGA
10
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$6.89M 2.22% 4,027,772 +398,809 +11% +$682K
IVC
11
DELISTED
Invacare Corporation
IVC
$6.59M 2.12% 887,246 +6,844 +0.8% +$50.8K
ANAB icon
12
AnaptysBio
ANAB
$569M
$6.27M 2.02% 443,877 +3,468 +0.8% +$49K
CHNG
13
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$36K 0.01% +3,639 New +$36K